Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

The Election 2016: A Scientist Reflects

Posted on November 15th, 2016 by in Pharma R&D

Like many of my science colleagues in the U.S., I was gobsmacked by the outcome of the presidential election last Tuesday. With some exceptions, most of my academic and industry colleagues were supporting the Clinton campaign in the general election. Continue reading “The Election 2016: A Scientist Reflects” »

2016 US Elections Fearful or Fertile Ground for Pharma?

Posted on November 10th, 2016 by in Pharma R&D

The elections outcome, the morning after, which is so fresh in everyone’s mind that we need to see how a Trump Presidency will shape the future growth of the US economy and in turn ultimately allow growth in innovation in Pharma Industry. Continue reading “2016 US Elections Fearful or Fertile Ground for Pharma?” »

R&D Innovation & Pharma Drug-Device Pricing

Posted on September 26th, 2016 by in Pharma R&D

The media as of late has given a lot of coverage to the “price gouging” that pharmaceutical company Mylan engaged in with its injection device EpiPen. Continue reading “R&D Innovation & Pharma Drug-Device Pricing” »